Barclays PLC Pa Vmed Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.41 $10,120 - $16,788	-11,907 Reduced 59.81%	8,000 $7,000
Q1 2022 May 16, 2022	SELL	$1.16 - $2.5 $88,520 - $190,777	-76,311 Reduced 79.31%	19,907 $27,000
Q4 2021 Feb 14, 2022	BUY	$2.46 - $8.74 $117,177 - $416,312	47,633 Added 98.04%	96,218 $237,000
Q3 2021 Nov 09, 2021	BUY	$5.1 - $9.39 $138,796 - $255,548	27,215 Added 127.35%	48,585 $415,000
Q2 2021 Aug 13, 2021	SELL	$3.95 - $6.88 $121,746 - $212,055	-30,822 Reduced 59.06%	21,370 $137,000
Q1 2021 May 13, 2021	BUY	$2.01 - $5.55 $80,112 - $221,206	39,857 Added 323.12%	52,192 $232,000
Q4 2020 Feb 11, 2021	SELL	$1.73 - $2.13 $7,485 - $9,216	-4,327 Reduced 25.97%	12,335 $26,000
Q3 2020 Nov 12, 2020	SELL	$1.76 - $2.17 $5,285 - $6,516	-3,003 Reduced 15.27%	16,662 $29,000
Q2 2020 Aug 12, 2020	BUY	$1.75 - $2.65 $34,413 - $52,112	19,665 New	19,665 $42,000
Q1 2020 May 13, 2020	SELL	$1.15 - $3.29 $1 - $3	-1 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.84 - $1.2 $0 - $1	1 New	1 $0

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $60.1M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.